1 / 10

Aarkstore Healthcare Market Access Vietnam

Healthcare infrastructure – Insightful review of the country’s healthcare system and health status with key health indicators are presented in this section.

jainsangam85
Télécharger la présentation

Aarkstore Healthcare Market Access Vietnam

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Healthcare Market Access: Vietnam – Aarkstore.com For More Information Visit : www.aarkstore.com For More Information Visit : www.aarkstore.com

  2. Summary The report provides in-depth information on: o Country Landscape – This section covers information on the prevailing economic environment in the country and dwells on both macro and micro economic indicators. The demographic profile of the country highlights the growing importance of middle class and increasing access to internet. It also captures the political landscape along with the opportunities and challenges presented by the country. o Healthcare infrastructure – Insightful review of the country’s healthcare system and health status with key health indicators are presented in this section. Moreover, healthcare expenditure and share of public and private sectors are prominently discussed in the section. The profiles of major hospitals and the number of healthcare personnel in the country are also comprehensively covered.o Overview of Pharmaceutical Market – This section depicts the pharmaceutical market in terms of size, growth, product mix and key players operating in the country. A special emphasis has been laid on the key drivers and barriers impacting the pharmaceutical market of the country. Furthermore, the profiles of major diseases with high burden for the country have been covered.  For More Information Visit : www.aarkstore.com

  3. Summary The report answers majority of key questions that are paramount for the success of a pharmaceutical company such as:• How stable is the country’s political climate, major economic indices like GDP size and growth, rate of inflation, FDI, etc. impacting the level of business sentiments• How lucrative is the pharmaceutical market of the country in terms of size, growth, product portfolio mix, key market segments and the level of competitive intensity • Who are the relevant stakeholders that needs to be engaged effectively for successful product commercialization• What are the key factors that influence the physician prescribing habits and payer/hospital formulary decisions• What are the key trends and policies that may impact the future market access landscape and how to effectively counter them• Which are the cost-containment measures that have been adopted by the country’s government and may be introduced in the near future • Which are the major disease segments that a pharmaceutical company can focus for product launch and growth based on the disease burden in the country• What are the key policies that impacts the pricing and reimbursement decisions in both public and private sector For More Information Visit : www.aarkstore.com

  4. Summary Key benefits / Why should you buy this report:As every country’s market access landscape is unique and evolving, it makes a prudent decision to have a country specific market access strategy. Moreover, the success of any pharmaceutical company hinges on successfully navigating challenges posed by the various stakeholders and regulatory bodies for effective product commercialization. This report will serve as a handy tool for pharmaceutical and other related healthcare stakeholders to:• Understand the macro and micro parameters that will play a pivotal role in making business decisions• Identify, segment, target and collaborate with the relevant stakeholders that hold key to effective product commercialization• Conceptualize and formulate plausible market access strategies based on the insights generated • Identify and foresee the major trends and policies likely to impact the regulatory, pricing and reimbursement landscape of the country• Capitalize on the opportunities presented by the country’s pharmaceutical market and mitigate the challenges posed by the competitors and stakeholders/regulatory bodies For More Information Visit : www.aarkstore.com

  5. Table of Content • COUNTRY LANDSCAPE 9 • HEALTHCARE INFRASTRUCTURE 34 • OVERVIEW OF PHARMACEUTICAL MARKET 60 • MARKET ACCESS 86 • APPENDIX 118 For More Information Visit : www.aarkstore.com

  6. List of Tables Table 1: GDP ($bn), Vietnam, 2009 - 2013 11Table 2: GDP per capita ($), Vietnam, 2009 - 2013 11Table 3: Real GDP growth (%), Vietnam, 2009 - 2013 12Table 4: Gross national income ($bn), Vietnam, 2009 - 2013 13Table 5: GNI per capita ($), Vietnam, 2009 - 2013 13Table 6: Inflation (%), Vietnam, 2009 - 2013 15Table 7: Consumer price index, Vietnam, 2009 - 2013 16Table 8: Foreign exchange reserves ($bn), Vietnam, 2009 - 2013 16Table 9: Current account balance ($bn), Vietnam, 2009 - 2013 17Table 10: Government net debt (% to GDP), Vietnam, 2009 - 2013 18Table 11: Exchange rate (VND per USD), Vietnam, 2009 - 2013 19Table 12: Foreign direct investment, Vietnam, 2009 - 2013 20Table 13: Foreign direct investment ($bn), Peer countries, 2009 - 2013 21Table 14: Imports and Exports ($bn), Vietnam, 2009 - 2012 22Table 15: Population (mn), Vietnam, 2009 - 2013 23 For More Information Visit : www.aarkstore.com

  7. List of Figures Figure 1: GDP ($bn), Peer countries, 2013 9Figure 2: GDP ($bn), Peer countries, 2013 10Figure 3: GDP per capita ($), Vietnam, 2009 - 2013 11Figure 4: Real GDP growth (%), Vietnam, 2009 - 2013 12Figure 5: Gross national income ($bn), Vietnam, 2009 - 2013 12Figure 6: GNI per capita ($), Vietnam, 2009 - 2013 13Figure 7: GNI, Peer countries, 2009 - 2013 14Figure 8: Inflation (%), Vietnam, 2009 - 2013 15Figure 9: Consumer price index, Vietnam, 2009 - 2013 15Figure 10: Foreign exchange reserves ($bn), Vietnam, 2009 - 2013 16 • Browse full report Or Sample Request @ • http://www.aarkstore.com/pharmaceuticals-healthcare/117424/healthcare-market-access-vietnam For More Information Visit : www.aarkstore.com

  8. Related Reports • Global Cephalosporin Drugs Industry 2015 Market Research Report • Europe Remifentanil Hydrochloride Industry Report 2015 • 2015 Gelatin Capsule Industry Report - Global and Chinese Market • Global Herbal Supplements and Remedies Industry 2015 Market Research Report • Global Cephalosporin Drugs Industry 2015 Market Research Report • Europe Remifentanil Hydrochloride Industry Report 2015 For More Information Visit : www.aarkstore.com

  9. Follow Us https://www.facebook.com/aarkstoredotcom https://twitter.com/aarkstore https://plus.google.com/+Aarkstoredotcom/posts https://www.linkedin.com/company/aarkstore-enterprise For More Information Visit : www.aarkstore.com

  10. Contact Us Office Address Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Mail us at contact@aarkstore.com 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 For More Information Visit : www.aarkstore.com

More Related